Share
.webp)
.webp)
.webp)
.webp)
Manher (AJ) Joshi
-Joshi-1.webp "Manher (AJ) Joshi")
Rhythm Pharmaceuticals, Inc, a global commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases, has appointed Manher “AJ” Joshi, M.D., as Chief Medical Officer.
Dr. Joshi joins Rhythm Pharmaceuticals with extensive experience in clinical development, medical affairs, and executive leadership across the biopharmaceutical industry. Most recently, he served as Chief Development Officer at Soleno Therapeutics, where he was responsible for advancing the company’s development programs.
Previously, Dr. Joshi served as Chief Medical Officer of Neurona Therapeutics. Before that, he held several leadership positions at Atara Biotherapeutics, including Executive Vice President, Chief Medical Officer, and Head of Clinical Development. His responsibilities across these roles included clinical development and strategic leadership as companies advanced innovative therapies through development.
Earlier in his career, Dr. Joshi held leadership positions spanning clinical development and medical affairs at Allergan Medical, Hunt Bioventures, Synageva BioPharma Corp., Genzyme, and HealthBanks. His broad industry experience encompasses multiple areas of drug development and provides a strong foundation for his new role at Rhythm Pharmaceuticals.
In his position as Chief Medical Officer, Dr. Joshi will contribute to Rhythm Pharmaceuticals’ efforts to advance therapies for patients living with rare neuroendocrine diseases and support the company’s clinical and medical development strategy.
Dr. Joshi earned his Bachelor of Arts degree from Boston University and his medical degree from Boston University School of Medicine. He completed his residency in Internal Medicine at Yale, adding a strong clinical foundation to his extensive biopharmaceutical leadership experience.
